Dawn Svoronos - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Global Blood Therapeutics Inc (GBT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Global Blood Therapeutics Inc (GBT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Global Blood Therapeutics Inc (GBT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dawn Svoronos made no insider transaction in PTC Therapeutics Inc (PTCT). Other recent insider transactions involving PTC Therapeutics Inc (PTCT) include a net sale of 25,597 shares made by Eric Pauwels , a net sale of 41,134 shares made by Christine Marie Utter , and a net sale of 28,914 shares made by Matthew B. Klein .

In summary, during the past 3 months, insiders sold 8,105 shares of PTC Therapeutics Inc (PTCT) in total and bought 0 shares, with a net sale of 8,105 shares. During the past 18 months, 273,917 shares of PTC Therapeutics Inc (PTCT) were sold and 7,700 shares were bought by its insiders, resulting in a net sale of 266,217 shares.

PTC Therapeutics Inc (PTCT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dawn Svoronos made 1 insider transaction in Xenon Pharmaceuticals Inc (XENE) with a net sale of 25,000. Other recent insider transactions involving Xenon Pharmaceuticals Inc (XENE) include a net sale of 30,570 shares made by Gary Patou , a net sale of 150,477 shares made by Simon N. Pimstone , and a net sale of 31,655 shares made by Ian Mortimer .

In summary, during the past 3 months, insiders sold 22,229 shares of Xenon Pharmaceuticals Inc (XENE) in total and bought 0 shares, with a net sale of 22,229 shares. During the past 18 months, 260,631 shares of Xenon Pharmaceuticals Inc (XENE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,631 shares.

Xenon Pharmaceuticals Inc (XENE)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Endocyte Inc (ECYT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Endocyte Inc (ECYT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Endocyte Inc (ECYT)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Medivation Inc (MDVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medivation Inc (MDVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Medivation Inc (MDVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dawn Svoronos made no insider transaction in Adverum Biotechnologies Inc (ADVM). Other recent insider transactions involving Adverum Biotechnologies Inc (ADVM) include a net purchase of 130,000 shares made by Lupher, Jr. Mark L. , a net purchase of 100,000 shares made by Linda M Rubinstein , and a net purchase of 100,000 shares made by James Paul Scopa .

In summary, during the past 3 months, insiders sold 0 shares of Adverum Biotechnologies Inc (ADVM) in total and bought 23,000 shares, with a net purchase of 23,000 shares. During the past 18 months, 6,810 shares of Adverum Biotechnologies Inc (ADVM) were sold and 33,000 shares were bought by its insiders, resulting in a net purchase of 26,190 shares.

Adverum Biotechnologies Inc (ADVM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Dawn Svoronos made 1 insider transaction in Acelyrin Inc (SLRN) with a net purchase of 15,000. Other recent insider transactions involving Acelyrin Inc (SLRN) include a net sale of 36,353 shares made by Shao-lee Lin , a net purchase of 1,310,000 shares made by Beth C Seidenberg , and a net purchase of 1,250,000 shares made by Westlake Biopartners Fund Ii, L.p. .

In summary, during the past 3 months, insiders sold 25,662 shares of Acelyrin Inc (SLRN) in total and bought 0 shares, with a net sale of 25,662 shares. During the past 18 months, 36,353 shares of Acelyrin Inc (SLRN) were sold and 2,647,332 shares were bought by its insiders, resulting in a net purchase of 2,610,979 shares.

Acelyrin Inc (SLRN)'s detailed insider trading history can be found in Insider Trading Tracker table.